Enveric Biosciences, Inc. Share Price & Technical Analysis
ENVB · $2.21 (-0.45%)
Healthcare / Biotechnology
$2.21
-0.45%
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylal…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
-41% return in May, 33% avg return in past 3 year May month.
12% return in 2026, -90% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -19% | -15% | -14% | 100% | -41% | – | – | – | – | – | – | – | 12% |
| 25 | -98% | 35% | -42% | -3% | -9% | 1% | -2% | -8% | -42% | -27% | -2% | -36% | -232% |
| 24 | -42% | 101% | -40% | 2% | -18% | -21% | -25% | 11% | -3% | 5% | -36% | 5% | -60% |
| 23 | 40% | -28% | -20% | 7% | 128% | -17% | -19% | -21% | 5% | -24% | -18% | -13% | 21% |
| 22 | -36% | -58% | 12% | -20% | -23% | 2% | -37% | -13% | -22% | -21% | -18% | -29% | -261% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$5.04M
P/E ratio
—
52W high
$17.64
52W low
$1.71
Volume
1,08,409
Beta
1.23
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Enveric Biosciences, Inc. share price today?
- Enveric Biosciences, Inc. (ENVB) last traded around $2.21 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ENVB have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ENVB. Download the app for real-time alerts.
- How can I analyze Enveric Biosciences, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.